PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1807076
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1807076
The global wound dressings market is projected to reach USD 15.87 billion by 2030 from USD 11.60 billion in 2025, at a CAGR of 6.5% during the forecast period.
Scope of the Report | |
---|---|
Years Considered for the Study | 2024-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Type, Wound Type, and End User |
Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
The market is primarily driven by the rising incidence of burn injuries, increasing prevalence of chronic, surgical, and traumatic wounds, a high rate of cesarean sections among elderly women, and a growing number of road accidents. However, the high cost and limited adoption of advanced wound dressings are anticipated to hinder market growth during the forecast period.
The advanced wound dressings segment accounted for the largest share of the wound dressings market, by type.
Based on type, the wound dressings market is segmented into traditional wound dressings and advanced wound dressings. In 2024, the advanced wound dressings segment captured the largest share of the wound dressings market by type. This can be largely attributed to the growing incidence of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, which require specialized and more effective treatment approaches. Additionally, factors such as the rising prevalence of diabetes, increased awareness among patients regarding wound management, advancements in wound care technologies, and the growing burden of hospital-acquired infections (HAIs) are contributing to the strong demand for advanced wound dressings. These products offer faster healing, reduced infection risk, and improved patient outcomes, further driving their adoption.
The surgical and traumatic wounds accounted for the largest market share in the wound dressings market.
Based on wound type, the market has been segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. Based on wound type, the surgical and traumatic wounds segment held the largest share of the wound dressings market in 2024. The significant share is primarily due to the rising number of surgical interventions worldwide and the increasing incidence of traumatic injuries resulting from accidents and falls. Furthermore, the growing elderly population, who are more prone to chronic conditions and surgeries, as well as the global rise in road traffic accidents, contribute to the segment's dominance. This segment is also projected to witness the highest CAGR during the forecast period, owing to continuous improvements in surgical techniques, post-operative care, and the increasing use of wound dressings in hospital and home care settings.
Asia Pacific is the fastest-growing region of the wound dressings market, by region.
The global wound dressings market is categorized into five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is experiencing rapid growth, driven by an aging population and a rising prevalence of lifestyle-related conditions that contribute to chronic wounds. The increasing demand for high-quality healthcare services, along with substantial investments in hospital infrastructure and advanced medical technologies, is fueling the uptake of advanced wound care dressings. Additionally, the growing medical tourism industry in countries such as India, Thailand, and Singapore has led to a rise in surgical procedures, thereby increasing the need for effective post-operative wound care. With a strong focus among healthcare providers on enhancing patient outcomes and shortening recovery periods, the Asia Pacific market is expected to register the highest compound annual growth rate (CAGR) during the forecast period.
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the wound dressings market are Solventum (US), Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Molnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Essity Aktiebolag (Sweden), Advanced Medical Solutions Group plc (UK), Mativ Holdings, Inc. (US), Owens & Minor (US), Lohmann & Rausher GmbH & Co. KG (Germany), Medline Industries, LP (US), DeRoyal Industries, Ine. (US), Winner Medical Co., LTD. (China), Advancis (UK), Hollister Incorporated (US), DermaRite Industries, LLC. (US), Mil Laboratories Pvt. Ltd. (India), Urgo Group (France), Gentell (US), Shield Line (US), and Focus Health Group (US)
Research Coverage
This report studies the wound dressings market based on type, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
rising incidence of burn injuries, rising use of regenerative medicine for wound management,
and government initiatives and reimbursement policies), restraints (high cost of advanced wound care products, risks associated with use of advanced wound care products
and antimicrobial resistance challenges), opportunities (Growth opportunities in emerging economies, technological advancement in wound care, and home-care optimized solutions), challenges (lack of trained healthcare professionals, Limited awareness in underdeveloped regions, and data security and privacy concerns)